Skip to main content
Premium Trial:

Request an Annual Quote

Lynx, Cue Pen Stem-Cell Gene-Expression Collaboration

NEW YORK, July 30 - Lynx Therapeutics and Cue Therapeutics today said they will collaborate to study stem-cell gene expression.

 

Terms of the agreement call for Lynx to apply its MPSS technology to Cue's astrocyte cells in hopes of uncovering certain factors in the maintenance of human astrocyte precursors, and perhaps also to other human stem cells.

 

The resulting data should serve as the groundwork for a stem-cell gene-expression database.

 

Click here for more information.

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.